Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)

Stock Selloff: What'd You Miss? (Full Show 02/08)
57:02 - Full episode of "What'd You Miss?" Guests: Russ Koesterich, BlackRock's global chief investment strategist, Peter Tchir, Brean Capital's head of macro strategy, Paul McNamara, GAM fund manager, and James Sweeney, chief economist at Credit Suisse. (Source: Bloomberg)
  • Why Canadian Miners Look Attractive to Global Buyers
  • Canadian Non-Bank Financials Are Our Biggest Short: Lloyd
  • JPMorgan: Gold Rally Breaks the Bullion Downtrend